H. Lundbeck A/S (HLBBF)
7.29
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
H. Lundbeck EPS Diluted (Quarterly) : 0.2616 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2616 |
| December 31, 2025 | -0.0042 |
| September 30, 2025 | 0.1739 |
| June 30, 2025 | 0.148 |
| March 31, 2025 | 0.1593 |
| December 31, 2024 | 0.0851 |
| September 30, 2024 | 0.1153 |
| June 30, 2024 | 0.112 |
| March 31, 2024 | 0.1476 |
| December 31, 2023 | 0.0195 |
| September 30, 2023 | 0.0994 |
| June 30, 2023 | 0.0883 |
| March 31, 2023 | 0.1277 |
| December 31, 2022 | 0.043 |
| September 30, 2022 | 0.0937 |
| June 30, 2022 | 0.0727 |
| March 31, 2022 | 0.0782 |
| December 31, 2021 | -0.0004 |
| September 30, 2021 | 0.064 |
| June 30, 2021 | 0.0771 |
| March 31, 2021 | 0.1265 |
| December 31, 2020 | 0.1114 |
| September 30, 2020 | 0.0815 |
| June 30, 2020 | 0.0971 |
| March 31, 2020 | 0.0171 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0263 |
| September 30, 2019 | 0.1408 |
| June 30, 2019 | 0.1492 |
| March 31, 2019 | 0.1719 |
| December 31, 2018 | 0.1258 |
| September 30, 2018 | 0.207 |
| June 30, 2018 | 0.201 |
| March 31, 2018 | 0.2488 |
| December 31, 2017 | 0.1099 |
| September 30, 2017 | 0.1745 |
| June 30, 2017 | 0.1136 |
| March 31, 2017 | 0.1064 |
| December 31, 2016 | 0.0866 |
| September 30, 2016 | 0.0607 |
| June 30, 2016 | 0.0448 |
| March 31, 2016 | 0.0347 |
| December 31, 2015 | -0.0833 |
| September 30, 2015 | -0.2383 |
| June 30, 2015 | -0.7367 |
| March 31, 2015 | -0.0155 |
| December 31, 2014 | -0.1351 |
| September 30, 2014 | 0.0013 |
| June 30, 2014 | 0.0335 |
| March 31, 2014 | 0.0776 |
| December 31, 2013 | 0.0055 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 1.709 |
| ALK-Abello A/S | 0.3088 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 259.64M |
| Revenue (Quarterly) | 1.100B |
| Total Expenses (Quarterly) | 840.47M |
| Enterprise Value | 8.616B |
| Gross Profit Margin (Quarterly) | 80.03% |
| Profit Margin (Quarterly) | 23.60% |
| Earnings Yield | 7.95% |
| Operating Earnings Yield | 14.96% |
| Normalized Earnings Yield | 9.566 |